Unaudited Consolidated Balance Sheets - USD ($) $ in Millions		Sep. 30, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents		$ 1,362	$ 1,263
Trade receivables - third party and affiliates		960	922
Non-trade receivables, net		624	545
Inventories		2,286	2,220
Assets held for sale		0	492
Other assets		258	251
Total current assets		5,490	5,693
Investments in affiliates		1,267	1,252
Property, plant and equipment, net		4,715	5,076
Operating lease right-of-use assets		426	359
Deferred income taxes		1,279	1,359
Other assets		571	601
Goodwill	[1]	4,150	4,171
Intangible assets, net		3,036	3,184
Total assets		20,934	21,695
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates		1,414	1,204
Trade payables - third party and affiliates		1,315	1,279
Liabilities held for sale		0	75
Other liabilities		1,479	1,049
Income taxes payable		142	76
Total current liabilities		4,350	3,683
Long-term debt, net of unamortized deferred financing costs		10,131	11,394
Deferred income taxes		369	512
Uncertain tax positions		222	208
Benefit obligations		312	344
Operating lease liabilities		329	265
Other liabilities		586	817
Commitments and Contingencies
Shareholders' Equity
Common stock, $0.0001 par value, 400,000,000 shares authorized (2026: 171,039,486 issued and 2025: 170,918,221 issued)		0	0
Treasury stock, at cost		(5,480)	(5,482)
Additional paid-in capital		459	431
Retained earnings		10,109	9,876
Accumulated other comprehensive income (loss), net		(872)	(776)
Total Celanese Corporation shareholders' equity		4,216	4,049
Noncontrolling interests		419	423
Total equity		4,635	4,472
Total liabilities and equity		$ 20,934	$ 21,695

[1] Includes accumulated impairment losses of $2.7 billion in the Engineered Materials segment.